NOW IS THE TIME TO CURE CYSTIC FIBROSIS.
For $100 a month, or just over $3.20 per day (the price of a cup of coffee), you can play a very important role in the cure for cystic fibrosis airway disease.
The Cure 4 Cystic Fibrosis Board invites you to join them as a valued member of 'The Circle'.
For a person living with cystic fibrosis time is their worst enemy. Every infection, every hospitalisation, every laboured breath takes its toll as the disease progressively damages their airways, making it harder for them to breathe. The resulting, irreversible damage to their lungs brings them a step closer to death. It is critical that we hasten our efforts towards a cure to give people living with this disease, and their families, the life they should be able to look forward to, the life they deserve to live.
If you too believe that now is the time to cure cystic fibrosis airway disease, we invite you, or your business, to join us by making an investment in this campaign. With your help, we will raise the funds required to ensure this promising research to cure cystic fibrosis airway disease can be translated in to the commencement of human clinical trials.
Please make your pledge and join 'The Circle' today.
We have a limited number of named fellowship opportunities available, if making a transformative gift to Cure 4 Cystic Fibrosis and the Adelaide CF Gene Therapy Research Group is something you are considering, please contact our Executive Officer, Suzy Dimaline on firstname.lastname@example.org. Your generous contribution is important to us and we believe each of our donors is special to our cause, which is why we look forward to contacting you to provide you with unique benefits that recognise and acknowledge your investment.
If you would like to learn more about our Major gift appeal please download our brochure here.
“It’s no longer a question of if a cure for cystic fibrosis airway disease will be found, but simply when. The fundamental science for a cure using gene therapy is there, it’s now a matter of improving its delivery. It’s the availability of funding that will determine how soon this gets over the line.”
Dr Nigel Farrow, researcher and father to Ella, 9, living with cystic fibrosis